EP1261331A4 - Procede et compositions permettant de traiter les maladies fibrosantes - Google Patents

Procede et compositions permettant de traiter les maladies fibrosantes

Info

Publication number
EP1261331A4
EP1261331A4 EP01910707A EP01910707A EP1261331A4 EP 1261331 A4 EP1261331 A4 EP 1261331A4 EP 01910707 A EP01910707 A EP 01910707A EP 01910707 A EP01910707 A EP 01910707A EP 1261331 A4 EP1261331 A4 EP 1261331A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treatment
methods
fibrotic diseases
fibrotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01910707A
Other languages
German (de)
English (en)
Other versions
EP1261331A1 (fr
Inventor
Steve I Rennard
Tadashi Kohyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Medical Center UNMC
Original Assignee
University of Nebraska Medical Center UNMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Medical Center UNMC filed Critical University of Nebraska Medical Center UNMC
Publication of EP1261331A1 publication Critical patent/EP1261331A1/fr
Publication of EP1261331A4 publication Critical patent/EP1261331A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01910707A 2000-02-16 2001-02-15 Procede et compositions permettant de traiter les maladies fibrosantes Withdrawn EP1261331A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18287600P 2000-02-16 2000-02-16
US182876P 2000-02-16
US22762900P 2000-08-24 2000-08-24
US227629P 2000-08-24
PCT/US2001/004797 WO2001060358A1 (fr) 2000-02-16 2001-02-15 Procede et compositions permettant de traiter les maladies fibrosantes

Publications (2)

Publication Number Publication Date
EP1261331A1 EP1261331A1 (fr) 2002-12-04
EP1261331A4 true EP1261331A4 (fr) 2005-01-05

Family

ID=26878513

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01910707A Withdrawn EP1261331A4 (fr) 2000-02-16 2001-02-15 Procede et compositions permettant de traiter les maladies fibrosantes

Country Status (4)

Country Link
EP (1) EP1261331A4 (fr)
JP (1) JP2004502643A (fr)
AU (1) AU2001238288A1 (fr)
WO (1) WO2001060358A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TR201815573T4 (tr) * 2002-05-28 2018-11-21 Astrazeneca Ab Topikal olarak uygulanabilir farmasötik preparasyon.
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JP2011513203A (ja) * 2008-03-14 2011-04-28 大塚製薬株式会社 Ｍｍｐ−２及び／又はｍｍｐ−９阻害剤
CN110099686B (zh) * 2016-08-26 2022-04-15 武田药品工业株式会社 非酒精性脂肪性肝病的治疗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225869B1 (en) * 1992-04-02 2007-11-28 Smithkline Beecham Corp Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0160358A1 *

Also Published As

Publication number Publication date
EP1261331A1 (fr) 2002-12-04
AU2001238288A1 (en) 2001-08-27
JP2004502643A (ja) 2004-01-29
WO2001060358A1 (fr) 2001-08-23

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
EP1324780A4 (fr) Procedes de traitement de l'arrhythmie cardiaque
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60227095D1 (de) Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE60138129D1 (de) Apparat zur behandlung von zähnen
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60103137D1 (de) Impstoff zur behandlung von atherosclerosis
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
EP1506001A4 (fr) Methodes et compositions de traitement de lesions epitheliales vaginales, cervicales et uterines
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60110748D1 (de) Behandlung von fluorkohlenstoff-beschickungen
DE60103685D1 (de) Behandlung von Poriomania
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60203878D1 (de) Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050614